Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HN.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
HN.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HN.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HN.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
HN.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HN.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
HN.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HN.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HN.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
HN.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HN.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HN.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HN.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HN.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HN.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HN.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HN.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HN.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
HN.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HN.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GJ.1.2.7NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
GJ.1.2.7NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
GJ.1.2.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GJ.1.2.7NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
GJ.1.2.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GJ.1.2.7NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
GJ.1.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
GJ.1.2.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.1.2.7NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GJ.1.2.7NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
GJ.1.2.7NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GJ.1.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GJ.1.2.7NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GJ.1.2.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GJ.1.2.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GJ.1.2.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GJ.1.2.7NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
GJ.1.2.7NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
GJ.1.2.7NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
GJ.1.2.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.1.2.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used